- Home
- LPSN vs XBIT Comparison
LPSN vs XBIT Comparison
Compare LPSN & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPSN
- XBIT
- Stock Information
- Founded
- LPSN 1995
- XBIT 2005
- Country
- LPSN United States
- XBIT United States
- Employees
- LPSN N/A
- XBIT N/A
- Industry
- LPSN EDP Services
- XBIT Pharmaceuticals and Biotechnology
- Sector
- LPSN Technology
- XBIT Health Care
- Exchange
- LPSN Nasdaq
- XBIT Nasdaq
- Market Cap
- LPSN 93.7M
- XBIT 86.3M
- IPO Year
- LPSN 2000
- XBIT 2015
- Fundamental
- Price
- LPSN $0.70
- XBIT $2.69
- Analyst Decision
- LPSN Hold
- XBIT
- Analyst Count
- LPSN 1
- XBIT 0
- Target Price
- LPSN N/A
- XBIT N/A
- AVG Volume (30 Days)
- LPSN 3.6M
- XBIT 51.1K
- Earning Date
- LPSN 11-06-2025
- XBIT 11-12-2025
- Dividend Yield
- LPSN N/A
- XBIT N/A
- EPS Growth
- LPSN N/A
- XBIT N/A
- EPS
- LPSN N/A
- XBIT N/A
- Revenue
- LPSN $271,750,000.00
- XBIT N/A
- Revenue This Year
- LPSN N/A
- XBIT N/A
- Revenue Next Year
- LPSN N/A
- XBIT N/A
- P/E Ratio
- LPSN N/A
- XBIT N/A
- Revenue Growth
- LPSN N/A
- XBIT N/A
- 52 Week Low
- LPSN $0.51
- XBIT $2.50
- 52 Week High
- LPSN $2.08
- XBIT $8.32
- Technical
- Relative Strength Index (RSI)
- LPSN 32.00
- XBIT 34.57
- Support Level
- LPSN $0.51
- XBIT $2.59
- Resistance Level
- LPSN $1.01
- XBIT $3.61
- Average True Range (ATR)
- LPSN 0.07
- XBIT 0.14
- MACD
- LPSN -0.03
- XBIT -0.04
- Stochastic Oscillator
- LPSN 37.38
- XBIT 12.06
About LPSN LivePerson Inc.
LivePerson Inc is the enterprise leader in digital customer conversation. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments, and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.